1. robflutie
2. rdjr2
3. ggordon100
4. 007Bondsman
5. prncsstss0
1.rdjr2 10/23/2017
They have a lot in the pipeline, so Friday was a blip
2.ggordon100 01/19/2018
Juno Therapeutics Inc May Be the Ideal Takeout Target for a Large Pharma like Celgene
3.robflutie 10/23/2017
Here is what is expected {Link}
4.rdjr2 01/24/2018
BMO Capital reiterates Buy rating, $144 PT
5.robflutie 01/26/2018
Canaccord Genuity reiterates buy rating, $140PT
6.robflutie 01/08/2018
$CELG. news.
7.robflutie 03/26/2018
Goldman Sachs cuts price target to $85 from $97
8.007Bondsman 01/22/2018
im ready
9.rdjr2 01/22/2018
Boom, buying Juno
10.robflutie 03/14/2018
RBC sees implied valuation floor; considers possibility of going private, takeout potential, $131PT
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW